PORT WASHINGTON, N.Y. (September 23, 2019)—Drive DeVilbiss Healthcare (Drive) announced that it agreed in principle to receive $35 million in new capital together with a reduction in cash debt service obligations from its current lenders. The transaction has broad support across Drive’s capital structure, including a substantial majority of Drive’s first and second lien lenders and new capital from the company’s primary equity holders.

ELYRIA, Ohio (September 20, 2019)—Invacare Corporation (IVC) announced the appointment of Julie Beck to its board of directors, effective Sept. 18, 2019. Beck currently serves as senior vice president and chief financial officer for NOVA Chemicals Corporation, a petrochemical company, a position she has held since 2016.

WASHINGTON, D.C. (September 20, 2019)—With the CB Round 2021 bid window closing Wednesday, The American Association for Homecare (AAHomecare) hopes to rally suppliers and other HME stakeholders to resume advocacy on HME policy priorities, including extending and expanding relief for non-bid rural suppliers (HR 2771), CRT-related legislation (HR 2293, S 1223, and HR 2408), and expected legislation on non-invasive ventilators in competitive bidding.

AMSTERDAM (September 17, 2019)—Royal Philips, a global provider of health technology, announced the commercial launch of Philips NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA). A mask-free alternative to existing positional OSA treatments, Philips NightBalance is a positional therapy that uses gentle vibrations to encourage users to alter their sleeping positions to help prevent apneas.